3.47 26-0109 Subject: National Prescription Opiate Litigation From: Office Of The City Attorney Recommendation: Adopt A Resolution Authorizing The City Attorney To: (1) Release The City's Potential Claims As Necessary To Join Eight National Settlement Agreements With Opioid Manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, And Zydus, And The Accompanying California State-Subdivision Agreements; And (2) Release The City's Claims Against Purdue Pharma And Sackler Entities As Necessary To Consent And Participate In The Accompanying Bankruptcy Plan And Settlement Agreements (Office Of The City Attorney - Public Nuisance, False Advertising, Unfair Competition); On The October 7, 2025 City Council Agenda On Consent - City of Oakland

Meeting: *Rules & Legislation Committee on 2025-09-25 10:30 AM

Meeting Time: September 25, 2025 at 10:30am PDT

Note: The online Request to Speak window has expired.

The online Comment window has expired

Agenda Item

3.47 26-0109 Subject: National Prescription Opiate Litigation From: Office Of The City Attorney Recommendation: Adopt A Resolution Authorizing The City Attorney To: (1) Release The City's Potential Claims As Necessary To Join Eight National Settlement Agreements With Opioid Manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, And Zydus, And The Accompanying California State-Subdivision Agreements; And (2) Release The City's Claims Against Purdue Pharma And Sackler Entities As Necessary To Consent And Participate In The Accompanying Bankruptcy Plan And Settlement Agreements (Office Of The City Attorney - Public Nuisance, False Advertising, Unfair Competition); On The October 7, 2025 City Council Agenda On Consent